47 U.K. Pharmaceuticals & Biotech Stocks - Strong Balance Sheet Stocks - Investing Ideas

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
OXB Oxford Biomedica	UK£3.24	2.7%	-27.5%	UK£323.5m	UK£4.30	PS3.6x	E100.4%	n/a
HCM HUTCHMED (China)	UK£3.24	-8.0%	57.3%	UK£2.8b	UK£4.44	PE34.9x	E18.7%	n/a
REDX Redx Pharma	UK£0.15	62.2%	-53.8%	UK£58.3m	UK£1.30	PS13.9x	E-22.3%	n/a
FUM Futura Medical	UK£0.40	0%	-7.2%	UK£119.7m	UK£1.26	PS38.6x	E111.8%	n/a
KNB Kanabo Group	UK£0.017	-2.9%	-40.4%	UK£10.8m	n/a	PS12x	n/a	n/a
TRX Tissue Regenix Group	UK£0.61	0%	12.8%	UK£43.3m	UK£1.20	PS1.9x	E133.0%	n/a
HEMO Hemogenyx Pharmaceuticals	UK£0.015	-1.6%	-28.7%	UK£20.3m	n/a	PB7.2x	n/a	n/a
SBTX SkinBioTherapeutics	UK£0.10	16.0%	-42.0%	UK£19.6m	n/a	PS121.1x	n/a	n/a
N4P N4 Pharma	UK£0.008	0%	-56.8%	UK£2.2m	n/a	PS1101x	n/a	n/a
PYC Physiomics	UK£0.013	0%	-54.5%	UK£1.7m	n/a	PS2.6x	n/a	n/a
RENE ReNeuron Group	UK£0.034	0%	-58.6%	UK£1.9m	n/a	PS7.7x	n/a	n/a
APH Alliance Pharma	UK£0.35	1.3%	-49.4%	UK£191.3m	n/a	PS1.1x	E47.8%	0%
IXI IXICO	UK£0.074	0%	-63.1%	UK£3.6m	n/a	PB0.3x	n/a	n/a
VRCI Verici Dx	UK£0.083	10.0%	-38.9%	UK£20.0m	n/a	PS1338.2x	S100.8%	n/a
HIK Hikma Pharmaceuticals	UK£19.78	-0.8%	8.3%	UK£4.4b	UK£22.93	PE29.4x	E16.0%	2.9%
SNG Synairgen	UK£0.07	5.7%	-28.2%	UK£14.1m	n/a	PB0.9x	E40.6%	n/a
ROQ Roquefort Therapeutics	UK£0.043	-4.4%	n/a	UK£5.6m	n/a	PS28.1x	n/a	n/a
BVX BiVictriX Therapeutics	UK£0.12	0%	-23.3%	UK£9.5m	n/a	PB3.4x	E63.8%	n/a
VAL ValiRx	UK£0.022	-27.9%	-77.4%	UK£2.9m	n/a	PS303.3x	n/a	n/a
ETX e-therapeutics	UK£0.09	-4.3%	-29.3%	UK£52.6m	n/a	PS154.7x	n/a	n/a
PBX ProBiotix Health	UK£0.043	0%	-15.0%	UK£5.2m	n/a	PS3.3x	n/a	n/a
IMM ImmuPharma	UK£0.024	11.1%	-25.1%	UK£10.0m	n/a	PS143.2x	n/a	n/a
AGY Allergy Therapeutics	UK£0.033	3.2%	n/a	UK£154.9m	n/a	PS2.9x	n/a	n/a

U.K. Pharmaceuticals & Biotech Strong Balance Sheet Stocks